Quantitative measurement of skeletal alkaline phosphatase to be used as an aid in the management of patients with Paget disease and osteoporosis.

Serum specimens with significant elevations of liver alkaline phosphatase may cause aberrantly elevated results with the Ostase® assay.

Patients who have undergone therapy that includes infusion with mouse monoclonal antibody may produce erroneous results.

1. Wyness SP, Roberts WL, Straseski JA. Pediatric reference intervals for four serum bone markers using two automated immunoassays. Clin Chim Acta. 2013 Jan 16; 415:169-172. PubMed 23122966

2. Cavalier E, Delanaye P. Analytical performance of a new bone-specific ALP automated immunoassay. J Am Soc Nephrol 24. 2013:754A.

3. Michelsen J, Wallaschofski H, Friedrich N, et al. Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone. 2013 Dec; 57(2):399-404. PubMed 24076251

Delmas PD. Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis. Am J Med. 1991; 91(5B):59S-63S. PubMed 1750421

van Straalen JP, Sanders E, Prummel MF, et al. Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta. 1991; 201(1-2):27-33. PubMed 1790624